Aurigene brings over 25 years of expertise in small-molecule CDMO solutions, providing a streamlined, end-to-end approach to meet your development and manufacturing needs.
Our fully integrated services guide you from early-stage development through to regulatory approval, ensuring your project aligns with global standards and achieves successful market entry. Equipped with advanced cGMP facilities and a 4,100 m³ capacity, we manage projects of all scales, delivering high-quality outcomes on time and within scope.
Our team of 700+ skilled scientists has completed over 400 projects, combining technical insight with practical experience to drive your vision forward. Partnering with Aurigene means choosing a dedicated team committed to excellence, precision, and your project’s success every step of the way.
Our Small Molecule Development and Manufacturing Services:
Aurigene Pharmaceutical Services offers specialized small molecule development with capabilities in process optimization, solid form screening, and high-containment handling. Our advanced facilities support complex chemistries, including cryogenic and high-pressure reactions, as well as continuous manufacturing for efficient scaling. With dedicated support for peptides, steroids, and mPEG derivatives, our process development labs and containment facilities ensure precision and safety at every stage. Aurigene ensures a seamless pathway from early development through to large-scale manufacturing, offering smooth tech transfer, in-depth analytical development, and robust IP and regulatory support for reliable market readiness.
Development Services
Manufacturing Services
Specialized Chemistry
Why Aurigene Pharmaceutical Services?
20+
years’ experience
900+
scientists
125+
global clients
600+
projects
19
NCEs
commercialized
16
USFDA inspected
cGMP facilities
6
Biologics
commercialized
3
manufacturing countries
UK, Mexico, India
Our Global Manufacturing Footprint
Drug Substance cGMP Facilities
- CTO-Mexico: Large-scale small molecule APIs, steroids and mPEG Alcohol
- CTO-Mirfield: Small molecule, prostaglandin and mPEG derivatives
- CTO-1, India: High potent and small molecule APIs
- CTO-2, India: Small molecule APIs and Nutraceuticals
- CTO-3, India: Low and medium scale small molecule APIs
- CTO-5, India: Large-scale small molecule APIs
- CTO-6, India: Small molecule, peptide, spray drying and high potent
- CTO-SEZ, India: Small molecule, continuous manufacturing, spray drying and high potent
*CTO - Chemical Technical Operations
Drug Product cGMP Facilities
- FTO-2: Regular OSDs (oral solid dosage forms)
- FTO-3: Regular OSDs
- FTO-7: Cyto parenterals and cyto and harmonal OSDs
- FTO-9: Non- cyto parenterals ophthalmics and BFS
- FTO-11: Parenterals cyto and non-cyto
- FTO-PU1: Regular OSDs
- FTO-PU2: Topicals, soft gelatin, and potent OSDs
*FTO - Formulation Technical Operations
Virtual Tour
Hyderabad R and D Center
Bangalore R and D Center
Connect with our scientific experts for your drug discovery, development, and manufacturing needs
We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.
Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.
Learning Resources
Role of Peptide Synthesis Based Drugs
Amino acids, peptides and proteins play multiple roles in the normal functioning of the body.Group of amino acids between 2 to 50 are called peptides. They often act as hormones and play diverse roles in the normal biological processes in the human body such as metabolism, intercellular signaling and neurotransmission.Peptide synthesis based drug have a high pote...
Read More
HPAPI Development at a Glance
The pharmaceutical industry's journey to improve patients' health has enhanced the number of more effective HPAPIs (High Potent Active Pharmaceutical Ingredient) in development pipelines. Traditionally, HPAPIs were exclusively concomitant with oncology therapeutics. ...
Read More
Discovery, Development and Manufacturing Services
Aurigene Pharmaceutical Services is a leading contract research, development and manufacturing organization which provides range of services to enable your IND/NDA filing ...
Read More
Technology meets sustainability - How a complex API development process goes green
We are always looking for ways to enhance the sustainability of our products and services. Our team successfully developed a scalable manufacturing process for the API product of one of our Biotech clients using eco-friendly manufacturing technologies. Read the case study to learn more....
Read More
Formal synthesis of Cladospolide C & epi-Cladospolide C using R- (þ)-g-valerolactone as a chiral synthon
2019
The formal synthesis of Cladospolide-C and its analog is achieved by using enantiopure (R)-g evalerolactone 10. The significant points of this synthesis are the stereoselective dihydroxylation of a, bunsaturated ester 16 using Sharpless protocol, Wittig olefination of g evalerolactol 6 with triphenylphosphonium iodide salt 7, one pot selective oxidation ...
Read More-
Development and assessment of a Bcs class II - SGLT2 (Sodium Glucose Cotransporter 2) inhibitor drug in the form of solid lipid Nanoparticles by selecting different lipids, co-surfactants, and manufacturing techniques
2005
Drug Delivery System (DDS) has been used successfully in the past few decades to cure illnesses and enhance health because of its improved systemic circulation and ability to regulate the drug's pharmacological action. As pharmacology and pharmacokinetics advanced, the idea of controlled release emerged, demonstrating the significance of drug release in assessing...
Read More -
Development of novel paullone-based PROTACs as anticancer agents
2005
Proteolysis-targeting chimera (PROTACs) represents a promising modality that has gained significant attention for cancer treatment. Using PROTAC technology, we synthesized novel structurally modified paullone-based PROTACs using Cereblon (CRBN) and Von Hippel–Lindau (VHL) E3 ligands....
Read More -
A simple RP-HPLC method development and verification of the Dissolution of Bromelain-A Complex mixture of proteolytic enzymes, in delayed release tablets
2005
Bromelain is a complex natural mixture of proteolytic enzymes derived from pineapple (Ananas cosmosus), which has good therapeutic properties. Bromelain can be found in all tissues of pineapple plants, including the stem, fruit, and leaves. Bromelain plays an important role in the treatment of many diseases such as soft tissue inflammation and edema, deep derma, ...
Read More
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market